The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
AQST · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
BBIO · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | AQST | BRKR | CFOR | BBIO |
|---|---|---|---|---|
| Moat Score (0–100) | 50 | 51 (highest) | 50 | 50 |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 29 | 55 | 80 (highest) | 58 |
| Pricing power | 93 (highest) | 80 | 49 | 91 |
| Returns on capital | — | 84 (highest) | 6 | — |
| Balance-sheet safety | 55 | 0 | 73 (highest) | 28 |
| Capital discipline | 24 | 34 | 44 (highest) | 24 |
| Price vs. high estimate | No price data | 178% above high estimate | No price data | No price data |
| Market cap | $481.5M | $8.5B | $142.1M | $15.7B |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |